Welcome to our dedicated page for Tilray Brands news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on Tilray Brands stock.
Tilray Brands, Inc. (NASDAQ: TLRY) is a pioneering company in the field of medical and recreational cannabis production and research. Headquartered in Canada, Tilray has positioned itself as a global leader with a commitment to providing safe, consistent, and reliable therapy to patients and consumers worldwide. The company operates in multiple regions, including Canada, the United States, Europe, Australia, and Latin America, serving a diverse clientele ranging from patients and physicians to pharmacies, hospitals, and governments.
In 2021, Tilray underwent a significant transformation when legacy Aphria acquired legacy Tilray through a reverse merger, consolidating their strengths under the name Tilray Brands, Inc. This strategic merger expanded Tilray's market reach and product portfolio, bolstering its position in both the medical cannabis export market and the recreational cannabis sector.
Tilray's core offerings include a comprehensive range of cannabis products, from medical cannabis treatments to CBD products and alcoholic beverages. One of its latest ventures is the Ridge Runner West Coast IPA, a craft beer that has gained popularity for its complex flavors and craftsmanship. Additionally, Tilray's subsidiary, Widmer Brothers Brewing, recently launched a new Hefe Variety 12 Pack, showcasing innovative wheat beer styles.
The company is also making strides in the cannabis beverage market with the introduction of XMG Zero and XMG+ beverages. These products offer a variety of THC and CBG ratios, bringing unique flavors and high-quality ingredients to consumers across Canada.
Tilray's commitment to innovation extends beyond beverages. Solei, one of its wellness brands, has introduced the Warming Deep Tissue Stick, a cannabis-infused topical solution designed for active lifestyle enthusiasts. Meanwhile, Good Supply has released the Twisted All-in-One rechargeable vape, offering a potent and flavorful vaping experience.
Overall, Tilray Brands, Inc. continues to lead the way in cannabis research, cultivation, and distribution, with a diversified portfolio that caters to the needs of a global community. The company remains dedicated to enhancing the lives of its consumers through high-quality, innovative products that inspire well-being.
Tilray Brands (Nasdaq: TLRY) expands its award-winning cannabis portfolio through its brand Good Supply. The new product release features high-potency strains, including Granddaddy Purps, Sour Diesel #2, and Frost Monster, with availability in 3.5g and 28g packages across Canada. Additionally, bestselling products like Monkey Butter and Sweet Berry Kush will be distributed coast to coast. Good Supply is recognized as a leading Canadian cannabis brand, catering to consumer preferences with an emphasis on quality and variety.
Breckenridge Distillery and Breckenridge Brewery have launched the second annual Buddy Pass, a limited edition whiskey and beer collaboration. This year, the Buddy Pass will be available in ten new markets starting October 24. The whiskey, with a proof of 114.7 and an MSRP of $49-$60, is crafted from Imperial Oatmeal Stout cask-aged bourbon, combining flavors of cinnamon, oak, and chocolate. The beer, a barrel-aged Imperial Oatmeal Stout, offers flavors of dark chocolate, espresso, and caramel. A $10 rebate is available when both products are purchased together in select markets.
Green Flash Brewing Company celebrates its 20th anniversary with a new WEST COAST IPA® lineup, featuring the classic beer alongside two new variants: Imperial West Coast IPA (8.9% ABV) and Hazy West Coast IPA (6.5% ABV). This year-round selection is now available in 12-ounce cans across the nation. The brand is also expanding its distribution into new states and plans to launch a WEST COAST IPA® Variety 24-pack by December. The refreshed branding emphasizes its San Diego roots and innovative craft beer offerings.
Tilray Brands reported net revenue of $153.2 million for the first fiscal quarter ended August 31, 2022. Adjusted EBITDA reached $13.5 million, marking the 14th consecutive quarter of positive results. The cannabis gross margin improved to 51%, up from 43% year-over-year. The company confirmed guidance for adjusted EBITDA between $70-$80 million and aims to achieve $130 million in cost savings. Tilray maintains the #1 cannabis market share in Canada and Germany, demonstrating strong performance amid macroeconomic challenges.
Tilray Brands has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under the Medical Cannabis Access Program (MCAP). The product now has reimbursement approval, enhancing accessibility for patients. This strategic move allows patients in Ireland to access Tilray’s full-spectrum medical cannabis oil solution. Tilray Medical, which operates in 22 countries, aims to expand its product offerings in accordance with local regulations. The company is committed to providing high-quality medical cannabis products, supporting patient health and well-being.
SweetWater Brewing Company, a subsidiary of Tilray Brands (NASDAQ: TLRY), announced the launch of its fall craft beer lineup, featuring the new H.A.Z.Y. Double IPA and the return of the Mosaic Single Hop Hazy IPA. The H.A.Z.Y. Double IPA (8.5% ABV) is characterized by tropical flavors and a smooth body, while the Mosaic IPA (6.2% ABV) offers complex citrus notes. Both beers will be available starting October 3 across select U.S. markets. This release coincides with SweetWater's 25th anniversary and includes a commitment to conservation initiatives, promoting clean water as part of its mission.
Tilray Brands, Inc. (Nasdaq: TLRY) announced it will release its financial results for Q1 fiscal 2023, ending August 31, 2022, on October 7, 2022, at 8:30 AM Eastern Time. A live audio webcast will discuss these results, accessible via the company's website. Investors can submit questions for the executive team until October 6, 2022, through the shareholder Q&A platform, Say Technologies. Tilray operates globally in the cannabis and consumer packaged goods sectors, committed to enhancing consumer well-being through its diverse product portfolio.
Tilray Brands has received approval from the Italian Ministry of Health to import and distribute its medical cannabis oral solution THC25 through its division, FL Group. This approval signifies a critical expansion into the Italian market, where it's expected to enhance patient access to medical cannabis. Tilray Medical operates in 22 countries and is known for its EU-GMP certified products. The company emphasizes its commitment to quality and responsible cannabis regulations, aiming to meet patient needs effectively.
Tilray Brands announces the launch of RIFF Drumsticks, a new range of premium infused pre-rolls, available across Ontario. Released on September 15, 2022, these limited-edition products are made with Granddaddy Purp whole flower, offering enhanced THC potency and fruity aromas. The unique pre-rolls are rolled in unbleached paper, dipped in distillate, and coated in kief for an elevated experience. The RIFF brand aims to connect with cannabis consumers seeking flavorful and potent products.
FAQ
What is the current stock price of Tilray Brands (TLRY)?
What is the market cap of Tilray Brands (TLRY)?
What does Tilray Brands, Inc. do?
Where is Tilray Brands, Inc. headquartered?
What was the significance of the 2021 merger?
What are some of Tilray's wellness products?
What recent product has Tilray introduced in the beverage market?
What is the Ridge Runner West Coast IPA?
What vaping product has Good Supply recently launched?
What markets does Tilray operate in?
What is the mission of Tilray Brands, Inc.?
How does Tilray ensure the quality of its products?
